|
|
Article: Acadia executive moves to start new company.(Acadia Pharmaceuticals Inc.)(Brief article)
- Article from:
- San Diego Business Journal
- Article date:
- October 30, 2006
- Author:
CopyrightCOPYRIGHT 2006 CBJ, L.P. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The chief scientific officer of Acadia Pharmaceuticals Inc., Mark Brann, is leaving the company to start Abbey Pharmaceuticals, which will focus on medications for substance abuse, especially alcoholism.
Acadia is providing $1 million upon Abbey's completion of an external equity financing.
Brann also resigned from his board member position at Acadia, which has around 100 ...